Quadrant Capital Group LLC Pmv Pharmaceuticals, Inc. Transaction History
Quadrant Capital Group LLC
- $1.43 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding PMVP
# of Institutions
78Shares Held
43.2MCall Options Held
3.1KPut Options Held
1.7K-
Orbimed Advisors LLC San Diego, CA6.48MShares$9 Million0.26% of portfolio
-
Sio Capital Management, LLC New York, NY3.57MShares$4.97 Million2.01% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.51MShares$4.88 Million0.08% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.47MShares$4.82 Million3.25% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$3.65 Million0.54% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $63.4M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...